Robert G. Savage

Chairman, President & Chief Executive Officer at Strategic Imagery LLC

Robert G. Savage

Robert G. Savage

Chairman, President & Chief Executive Officer at Strategic Imagery LLC

Overview
Career Highlights

Ortho-McNeil Pharmaceutical LLC
Johnson & Johnson
Strategic Imagery LLC

RelSci Relationships

2317

Number of Boards

16

Birthday

1954

Age

67

Relationships
RelSci Relationships are individuals Robert G. Savage likely has professional access to. A relationship does not necessarily indicate a personal connection.

Chief Clinical Advisor at Cytogel Pharma LLC

Relationship likelihood: Strong

Former Chief Executive Officer at Quintiles Transnational Corp.

Relationship likelihood: Strong

Chief Executive Officer at Squarex

Relationship likelihood: Strong

Chief Executive Officer at Rempex Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Executive Officer at Humanigen, Inc.

Relationship likelihood: Strong

Former Audit Partner at Ernst & Young LLP

Relationship likelihood: Strong

Founder & Partner at Petersen, Waldheim & Cie. GmbH

Relationship likelihood: Strong

Chairman & Chief Financial Officer at The Kitchen LLC

Relationship likelihood: Strong

Former Audit Partner at Ernst & Young LLP

Relationship likelihood: Strong

Executive Chairman of the Board & Chief Executive Officer at Strongbridge Biopharma PLC

Relationship likelihood: Strong

Paths to Robert G. Savage
Potential Connections via
Relationship Science
You
Robert G. Savage
Chairman, President & Chief Executive Officer at Strategic Imagery LLC
Education
B.S. in Biology

Upsala College was a private college affiliated with the Swedish-American Augustana Synod (now the Augustana Evangelical Lutheran Church) and located in East Orange in Essex County, New Jersey in the United States. Originally founded in 1893 in Brooklyn, in New York City, Upsala later moved to Kenilworth, New Jersey, and finally to East Orange in 1924. In the 1970s, Upsala considered moving to Wantage Township in rural Sussex County (where it opened a satellite campus) as East Orange's crime problem and social conditions deteriorated. However, college administration and trustees chose to remain committed to East Orange. Declining enrollment and financial difficulties forced the school to close in 1995.

MBA

Rutgers Business School – Newark and New Brunswick (Rutgers Business School, RBS) is the graduate and undergraduate business school located on the Newark and New Brunswick campuses of Rutgers University. It was founded in 1929. Rutgers Business School offers bachelor's, master's, and Ph.D. degrees. It offers Master of Business Administration (MBA) degrees with concentrations in Accounting, Finance, Supply Chain Management, Pharmaceutical Management, Marketing, Market Research, Insights, & Analytics, Entrepreneurship, Management & Business Strategy, Global Business, and Information Management & Analytics. A concentration in Real Estate was added to the curriculum in 2013. The Rutgers Business School also offers a 14-month MBA in Public Accounting and masters degrees in Accounting (MACCY), Quantitative Finance (MQF), and Information Technology (MIT).

Career History
Chairman, President & Chief Executive Officer
2003 - Current
Group Vice President & President, General Therapeutics & Inflammation Business
2002 - 2003

Pharmacia Corp. developed, manufactured and marketed pharmaceutical products. Prescription pharmaceuticals included general therapeutics, ophthalmology and hospital products including oncology and diversified therapeutics. It also operated in consumer health care, animal health, diagnostics and contract manufacturing and bulk pharmaceutical chemicals. The customers of the group were pharmacies, hospitals, chain warehouses, governments, physicians, wholesalers and other distributors. It was headquartered in Peapack, NJ.

President
1998 - 2000

Ortho-McNeil Pharmaceutical LLC manufactures pharmaceutical products. Its products include ditropan, elmiron, modicon, otho cept and ortho novum etc. The company was founded in 1993 and is headquartered in Raritan, NJ.

Boards & Committees
Independent Director
2012 - 2015

MergeWorthRx Corp. operates as a acquisition company. The company's purpose is to enter into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination, one or more businesses or entities. It expects to focus on the United States healthcare industry. The company was founded by Anthony Minnuto, Charles F. Fistel and Stephen B. Cichy on January 22, 2013 and is headquartered in Miami, FL.

Director
Prior - 2006

EpiCept Corporation is a specialty pharmaceutical company focused on the development and commercialization of topically-delivered prescription pain management therapeutics. EpiCept has six products in clinical development for the treatment of various types of pain: three are ready to enter, or have entered, pivotal Phase IIb or Phase III clinical trials

Chairman
2004 - 2013

EpiCept Corp. is a pharmaceutical company, which focuses on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company focuses on analgesics targeting peripheral nerve receptors and cancer therapies. Its lead product Ceplene, is used concomitantly with low-dose interleukin-2, is intended as remission maintenance therapy in the treatment of acute myeloid leukemia for adult patients. The company's other oncology compounds include AmiKet, a late-stage pain product candidate for the treatment of peripheral neuropathies, and two other oncology compounds in clinical development, that that were discovered using in-house technology and have been shown to act as vascular disruption agents in solid tumors. EpiCept was founded in March 1993 and is headquartered in Tarrytown, NY.

Political Donations
$212
2011

Former President of United States

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Robert G. Savage. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Robert G. Savage's profile does not indicate a business or promotional relationship of any kind between RelSci and Robert G. Savage.